The mediating role of inflammation in cancer risk among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study
Individuals with MASLD, MetALD, or ALD are at increased risk of all cancer, and the inflammation mediates the effect of MASLD. These findings highlight the importance of cancer screening and prevention in patients with MASLD or MetALD.
Authors
- Zixin Liang (ORCID: https://orcid.org/0000-0002-6621-8841)
- Ningning Mi (ORCID: https://orcid.org/0000-0003-1752-185X)
- Bin Xia (ORCID: https://orcid.org/0000-0003-4340-733X)
- Peng Xie
- Shijian Xiang (ORCID: https://orcid.org/0000-0002-7119-5728)
- Man Yang (ORCID: https://orcid.org/0000-0002-4443-9379)
- Jinqiu Yuan
- Jian-Hua Bu
- Changrui Long
- Qiangsheng He
- Anran Liu
Institutions
- Sun Yat-sen University (CN)
- Gansu University of Traditional Chinese Medicine (CN)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
- Gansu Provincial Hospital (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1097/js9.0000000000004181
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00